Search

everythinglearnresearchcommunity

for

Search:↓

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Oral pigmentation can be a sign of Addison's disease.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Lichen planopilaris can unusually affect only the face, causing pigmentation and scarring.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Lichen planopilaris can be accurately diagnosed and effectively treated.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

FFA has higher long-term remission rates than LPP.

Finasteride doesn't negatively affect sexual function in Indian men with hair loss.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

Pellagra, caused by niacin deficiency and presenting with photosensitivity, should be considered in patients with relevant symptoms and risk factors.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.